264 related articles for article (PubMed ID: 11142756)
21. Tay-Sachs disease as a model for screening inborn errors.
Blitzer MG; McDowell GA
Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
[TBL] [Abstract][Full Text] [Related]
22. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
[TBL] [Abstract][Full Text] [Related]
23. Tay-Sachs disease screening and diagnosis: evolving technologies.
Hechtman P; Kaplan F
DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
[TBL] [Abstract][Full Text] [Related]
24. Determinants of utilization of Tay-Sachs screening.
Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
[TBL] [Abstract][Full Text] [Related]
25. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
Clark M; Palmer R; Kontras S
Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
[No Abstract] [Full Text] [Related]
26. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
[TBL] [Abstract][Full Text] [Related]
27. Tay-Sachs disease carrier screening: follow-up of a case-finding approach.
Clarke JT; Skomorowski MA; Zuker S
Am J Med Genet; 1989 Dec; 34(4):601-5. PubMed ID: 2624277
[TBL] [Abstract][Full Text] [Related]
28. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
Rogers JF; Hogan EL; Jorgenson RJ
South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
[TBL] [Abstract][Full Text] [Related]
29. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
Cantor RM; Lim JS; Roy C; Kaback MM
Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
[TBL] [Abstract][Full Text] [Related]
30. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
31. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
Gason AA; Aitken M; Delatycki MB; Sheffield E; Metcalfe SA
Genet Med; 2004; 6(4):226-31. PubMed ID: 15266211
[TBL] [Abstract][Full Text] [Related]
32. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
Zeesman S; Clow CL; Cartier L; Scriver CR
Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a Tay-Sachs screening program on a college campus.
Krischer JP; Savitt TL; Spring A; Wallace SE; Garnica AD; Frias JL
South Med J; 1982 Feb; 75(2):169-74. PubMed ID: 7058357
[TBL] [Abstract][Full Text] [Related]
34. Computer assisted small-scale Tay-Sachs carrier screening.
Toney JH; Quirk JM
J Appl Biochem; 1983; 5(1-2):25-30. PubMed ID: 6236193
[TBL] [Abstract][Full Text] [Related]
35. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
Colaianni A; Chandrasekharan S; Cook-Deegan R
Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
Peleg L; Gazit E; Goldman B; Akstein E
Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
[No Abstract] [Full Text] [Related]
37. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
[TBL] [Abstract][Full Text] [Related]
38. The ovrselling of genetic anxiety.
Goodman MJ; Goodman LE
Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291
[TBL] [Abstract][Full Text] [Related]
39. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.
Bach G; Tomczak J; Risch N; Ekstein J
Am J Med Genet; 2001 Feb; 99(1):70-5. PubMed ID: 11170098
[TBL] [Abstract][Full Text] [Related]
40. Carrier screening for Tay-Sachs.
Ellis I
Nursing (Lond); 1991 Sep 12-25; 4(41):16-8. PubMed ID: 1945106
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
